Enoxaparin

Products Enoxaparin is commercially available as a solution for injection (Clexane). It has been approved in many countries since 1988. Biosimilars were released in the EU in 2016 and in many countries in 2020 (Inhixa). Structure and properties Enoxaparin is present in the drug as enoxaparin sodium, the sodium salt of a low-molecular-weight heparin (LMWH) … Enoxaparin

Biperides

Products Biperiden is commercially available as tablets, sustained-release tablets, and a solution for injection (Akineton, Akineton retard). It has been approved in many countries since 1958. Structure and properties Biperiden (C21H29NO, Mr = 311.46 g/mol) is present in drugs as biperidene hydrochloride, a white crystalline powder that is sparingly soluble in water. It is a … Biperides

Susoctocog Alfa

Products Susoctocog alfa is commercially available as a powder and solvent for solution for injection (Obizur). It was approved in the United States in 2014, in the EU in 2015, and in many countries in 2016. Structure and properties Susoctocog alfa is a recombinant derivative of porcine blood clotting factor VIII lacking the B domain. … Susoctocog Alfa

Suxamethonium Chloride

Products Suxamethonium chloride is commercially available as a solution for injection (lysthenone, succinoline). It was introduced in the 1950s and has been approved in many countries since 1954. Suxamethonium chloride is also known as succinylcholine or succinylcholine chloride, especially in English. In jargon, it is also called Suxi or Sux. Structure and properties Suxamethonium chloride … Suxamethonium Chloride

Damoctocog Alfa Pegol

Products Damoctocog alfa pegol was approved as a preparation for solution for injection in the United States and the EU in 2018 and in many countries in 2019 (Jivi). Structure and properties Damoctocog alfa pegol is a pegylated, B-domain-deleted, conjugated, recombinant blood coagulation factor VIII (rFVIII). The molecular mass is approximately 234 kDa. The drug … Damoctocog Alfa Pegol

Satralizumab

Products Satralizumab was approved in many countries in 2020 as a solution for injection (Enspryng). Structure and properties Satralizumab is a humanized IgG2 monoclonal antibody produced by biotechnological methods. Effects Satralizumab (ATC L04AC19) has anti-inflammatory and immunosuppressive properties. The effects are due to binding to the soluble and membrane-bound human IL-6 receptor (IL-6R), preventing signal … Satralizumab

Thiamine (Vitamin B1)

Products Thiamine (vitamin B1) is commercially available in tablet form and as a solution for injection (e.g., Benerva, Neurorubin, generics), among others. It is a component of numerous combination preparations (e.g., Berocca). Structure and properties Thiamine (C12H17N4OS+, Mr = 265.4 g/mol) is usually present in drugs as thiamine nitrate or thiamine hydrochloride. Thiamine hydrochloride, unlike … Thiamine (Vitamin B1)

Lokivetmab

Products Lokivetmab was approved in the EU in 2017 and in many countries in 2018 in the form of a solution for injection (Cytopoint, Zoetis Belgium SA). Lokivetmab was the first monoclonal antibody to be cleared for animals. In the United States, locivetmab was approved in 2015 (Canine Atopic Dermatitis Immunotherapeutic). Structure and properties Lokivetmab … Lokivetmab

Eftrenonacog Alfa

Products Eftrenonacog alfa was approved in the United States in 2014 and in the EU and many countries in 2016 as a powder and solvent for solution for injection (Alprolix). Structure and properties Eftrenonacog alfa is a recombinant fusion protein consisting of human coagulation factor IX covalently linked to the Fc fragment of human immunoglobulin … Eftrenonacog Alfa

Tranexamic Acid

Products Tranexamic acid is commercially available in the form of film-coated tablets and effervescent tablets (Cyklokapron). It has been approved in many countries since 1968. In 2016, a solution for injection was also released. This article refers to peroral administration. Structure and properties Tranexamic acid (C8H15NO2, Mr = 157.2 g/mol) exists as a white crystalline … Tranexamic Acid

Buprenorphine

Products Buprenorphine is commercially available as sublingual tablets, transdermal patch and injection solution, and depot injection solution (e.g., Temgesic, Transtec, Subutex, generics). It has been approved in many countries since 1979. Structure and properties Buprenorphine (C29H41NO4, Mr = 467.6 g/mol) is present in drugs as buprenorphine hydrochloride, a white crystalline powder that is sparingly soluble … Buprenorphine

Alfentanil

Products Alfentanil is commercially available as a solution for injection (Rapifen). It has been approved in many countries since 1983. Structure and properties Alfentanil (C21H32N6O3, Mr = 416.5 g/mol) is a 4-anilidopiperidine and a tetrazole derivative. It is present in the drug as alfentanil hydrochloride, a white powder that is readily soluble in water. The … Alfentanil